In human sera from endemic regions, approximately 32% showed IgA reactivity to these rVI epitopes, reinforcing their relevance in natural infection.Pinpointing whether merozoite-targeted IgA confers substantive protection or primarily influences disease pathology warrants further human clinical studies, as most data currently derive from animal or in vitro systems. Here, CD79A is linked to infection.